Auna S.A. (AUNA) delivered earnings and revenue surprises of -42.31% and +2.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Cerenome (CNSY) delivered earnings and revenue surprises of -36.46% and -60.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Fate Therapeutics (FATE) delivered earnings and revenue surprises of +10.71% and +108.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Auna S.A. (AUNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Surgery Partners (SGRY) delivered earnings and revenue surprises of +400.00% and +1.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Progyny (PGNY) delivered earnings and revenue surprises of +7.84% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Revvity (RVTY) delivered earnings and revenue surprises of +14.63% and +3.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Avantor (AVTR) delivered earnings and revenue surprises of +10.53% and +4.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
